| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.99 | 0.002 | 0.99 | Spasmolytic | 0.884 0.003 DBMET02396 0.965 0.002 DBMET00945 0.816 0.004 DBMET02395 0.311 0.066 DB09269 | ||
| 0.93 | 0.004 | 0.964 | Toll-Like receptor 7 agonist | 0.943 0.004 DBMET02396 0.882 0.004 DBMET00945 0.964 0.004 DBMET02395 0.633 0.014 DB09269 | DBMET02395 | |
| 0.929 | 0.004 | 0.964 | Toll-Like receptor agonist | 0.943 0.004 DBMET02396 0.879 0.005 DBMET00945 0.964 0.004 DBMET02395 0.63 0.014 DB09269 | DBMET02395 | |
| 0.858 | 0.003 | 0.926 | Bronchodilator | 0.726 0.004 DBMET02396 0.604 0.004 DBMET00945 0.926 0.003 DBMET02395 0.105 0.058 DB09269 | DBMET02395 | |
| 0.853 | 0.002 | 0.853 | Cholinergic antagonist | 0.674 0.003 DBMET02396 0.784 0.003 DBMET00945 0.579 0.004 DBMET02395 | ||
| 0.838 | 0.002 | 0.838 | Acetylcholine antagonist | 0.662 0.004 DBMET02396 0.778 0.003 DBMET00945 0.568 0.004 DBMET02395 | ||
| 0.788 | 0.002 | 0.788 | Acetylcholine muscarinic antagonist | 0.59 0.003 DBMET02396 0.694 0.003 DBMET00945 0.478 0.004 DBMET02395 0.103 0.087 DB09269 | ||
| 0.779 | 0.002 | 0.779 | Acetylcholine M1 receptor antagonist | 0.526 0.004 DBMET02396 0.503 0.004 DBMET00945 0.515 0.004 DBMET02395 0.149 0.076 DB09269 | ||
| 0.739 | 0.005 | 0.786 | Cardiotonic | 0.716 0.005 DBMET02396 0.517 0.014 DBMET00945 0.786 0.004 DBMET02395 0.17 0.152 DB09269 | DBMET02395 | |
| 0.577 | 0.003 | 0.577 | Acetylcholine M2 receptor antagonist | 0.44 0.003 DBMET02396 0.26 0.005 DBMET00945 0.324 0.004 DBMET02395 | ||
| 0.504 | 0.01 | 0.504 | Psychostimulant | 0.412 0.021 DBMET02396 0.417 0.02 DBMET00945 0.433 0.018 DBMET02395 0.338 0.034 DB09269 | ||
| 0.464 | 0.004 | 0.464 | Acetylcholine nicotinic antagonist | 0.224 0.011 DBMET02396 0.19 0.014 DBMET00945 0.228 0.01 DBMET02395 | ||
| 0.458 | 0.003 | 0.458 | Acetylcholine M3 receptor antagonist | 0.377 0.003 DBMET02396 0.218 0.005 DBMET00945 0.289 0.004 DBMET02395 | ||
| 0.443 | 0.003 | 0.443 | Acetylcholine M4 receptor antagonist | 0.227 0.005 DBMET02396 0.172 0.008 DBMET00945 0.193 0.006 DBMET02395 | ||
| 0.393 | 0.019 | 0.453 | Sodium/bile acid cotransporter inhibitor | 0.272 0.105 DBMET02396 0.304 0.075 DBMET02395 0.453 0.007 DB09269 | DB09269 | |
| 0.349 | 0.014 | 0.349 | Cytidine deaminase inhibitor | 0.299 0.019 DBMET02396 0.188 0.053 DBMET00945 0.275 0.023 DBMET02395 0.129 0.092 DB09269 | ||
| 0.35 | 0.064 | 0.571 | Cholesterol antagonist | 0.281 0.103 DBMET02396 0.205 0.16 DBMET00945 0.363 0.059 DBMET02395 0.571 0.022 DB09269 | DB09269 | |
| 0.274 | 0.004 | 0.274 | Acetylcholine M5 receptor antagonist | 0.136 0.009 DBMET02396 0.097 0.018 DBMET00945 0.159 0.007 DBMET02395 | ||
| 0.251 | 0.013 | 0.251 | Expectorant | 0.231 0.015 DBMET02396 0.163 0.031 DBMET00945 0.233 0.015 DBMET02395 0.249 0.013 DB09269 | ||
| 0.252 | 0.02 | 0.262 | Anesthetic local | 0.249 0.02 DBMET02396 0.262 0.018 DBMET00945 0.247 0.021 DBMET02395 0.113 0.072 DB09269 | DBMET00945 | |
| 0.218 | 0.01 | 0.253 | Mucolytic | 0.208 0.012 DBMET02396 0.152 0.031 DBMET00945 0.205 0.012 DBMET02395 0.253 0.006 DB09269 | DB09269 | |
| 0.288 | 0.082 | 0.521 | Interleukin 2 agonist | 0.327 0.057 DBMET02396 0.201 0.188 DBMET00945 0.402 0.027 DBMET02395 0.521 0.006 DB09269 | DB09269 | |
| 0.216 | 0.03 | 0.706 | Alpha-N-acetylglucosaminidase inhibitor | 0.173 0.043 DBMET02396 0.134 0.066 DBMET00945 0.473 0.006 DBMET02395 0.706 0.003 DB09269 | DB09269 | |
| 0.249 | 0.07 | 0.262 | Angiogenesis stimulant | 0.176 0.107 DBMET00945 0.193 0.098 DBMET02395 0.262 0.065 DB09269 | DB09269 | |
| 0.214 | 0.056 | 0.214 | P-glycoprotein inhibitor | 0.149 0.119 DBMET02396 0.17 0.09 DB09269 | ||
| 0.181 | 0.027 | 0.311 | Cyclooxygenase 3 inhibitor | 0.168 0.034 DBMET02396 0.311 0.005 DB09269 | DB09269 | |
| 0.163 | 0.011 | 0.163 | Neuronal nicotinic receptor antagonist | 0.107 0.022 DBMET02396 0.089 0.029 DBMET00945 0.152 0.012 DBMET02395 | ||
| 0.16 | 0.015 | 0.18 | Acetylcholine M3 receptor agonist | 0.18 0.007 DBMET02396 0.171 0.01 DBMET00945 0.173 0.009 DBMET02395 | DBMET02396 | |
| 0.234 | 0.099 | 0.514 | 5 Hydroxytryptamine uptake stimulant | 0.416 0.012 DBMET02396 0.42 0.011 DBMET00945 0.421 0.011 DBMET02395 0.514 0.004 DB09269 | DB09269 | |
| 0.186 | 0.052 | 0.219 | MAP kinase kinase 5 inhibitor | 0.183 0.057 DBMET02396 0.172 0.082 DBMET00945 0.219 0.017 DBMET02395 | DBMET02395 | |
| 0.157 | 0.028 | 0.189 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 DBMET02396 0.145 0.056 DBMET00945 0.174 0.01 DBMET02395 0.189 0.005 DB09269 | DB09269 | |
| 0.251 | 0.127 | 0.412 | Transcription factor NF kappa B inhibitor | 0.412 0.061 DB09269 | DB09269 | |
| 0.127 | 0.009 | 0.127 | Acetylcholine M5 receptor agonist | 0.077 0.037 DBMET02396 0.084 0.031 DBMET02395 | ||
| 0.167 | 0.05 | 0.225 | Cell wall synthesis inhibitor | 0.116 0.106 DBMET02396 0.129 0.087 DBMET00945 0.225 0.022 DBMET02395 0.181 0.039 DB09269 | DBMET02395 | |
| 0.182 | 0.069 | 0.255 | Lipocortins synthesis antagonist | 0.161 0.091 DBMET02396 0.145 0.113 DBMET02395 0.255 0.032 DB09269 | DB09269 | |
| 0.138 | 0.028 | 0.143 | Toll-Like receptor 4 antagonist | 0.143 0.025 DBMET02396 0.096 0.076 DBMET00945 0.121 0.042 DB09269 | DBMET02396 | |
| 0.2 | 0.094 | 0.465 | Hypolipemic | 0.465 0.016 DB09269 | DB09269 | |
| 0.184 | 0.084 | 0.554 | Anesthetic general | 0.195 0.077 DBMET02396 0.344 0.025 DBMET02395 0.554 0.005 DB09269 | DB09269 | |
| 0.236 | 0.138 | 0.524 | Antithrombotic | 0.223 0.151 DBMET02396 0.211 0.164 DBMET02395 0.524 0.026 DB09269 | DB09269 | |
| 0.152 | 0.067 | 0.152 | Lipid peroxidase inhibitor | 0.127 0.087 DB09269 | ||
| 0.102 | 0.02 | 0.151 | Glycine receptor agonist | 0.083 0.035 DBMET02396 0.076 0.045 DBMET00945 0.136 0.009 DBMET02395 0.151 0.007 DB09269 | DB09269 | |
| 0.289 | 0.206 | 0.577 | Caspase 9 stimulant | 0.308 0.185 DBMET02396 0.342 0.152 DBMET00945 0.466 0.075 DBMET02395 0.577 0.04 DB09269 | DB09269 | |
| 0.112 | 0.04 | 0.131 | Acetylcholine agonist | 0.09 0.055 DBMET02396 0.131 0.032 DBMET02395 | DBMET02395 | |
| 0.091 | 0.019 | 0.091 | Acetylcholine muscarinic agonist | 0.064 0.031 DBMET02396 0.088 0.02 DBMET02395 | ||
| 0.158 | 0.091 | 0.343 | Phospholipase C inhibitor | 0.191 0.051 DBMET02395 0.343 0.015 DB09269 | DB09269 | |
| 0.232 | 0.169 | 0.434 | Calcium channel activator | 0.266 0.128 DBMET02396 0.223 0.18 DBMET00945 0.298 0.094 DBMET02395 0.434 0.014 DB09269 | DB09269 | |
| 0.071 | 0.014 | 0.071 | Dopamine D5 antagonist | |||
| 0.145 | 0.094 | 0.257 | Arachidonic acid antagonist | 0.133 0.109 DBMET02396 0.18 0.053 DBMET02395 0.257 0.004 DB09269 | DB09269 | |
| 0.069 | 0.017 | 0.145 | Nicotinic receptor alpha4 subunit antagonist | 0.096 0.009 DBMET02396 0.084 0.012 DBMET00945 0.145 0.004 DBMET02395 | DBMET02395 | |
| 0.283 | 0.232 | 0.578 | Antiinflammatory | 0.578 0.06 DB09269 | DB09269 | |
| 0.095 | 0.047 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.08 0.079 DBMET02395 | ||
| 0.178 | 0.132 | 0.25 | Peptidyltransferase inhibitor | 0.25 0.05 DBMET02395 0.243 0.056 DB09269 | DBMET02395 | |
| 0.067 | 0.022 | 0.119 | Dopamine transporter inhibitor | 0.105 0.011 DBMET02396 0.099 0.012 DBMET00945 0.119 0.009 DBMET02395 | DBMET02395 | |
| 0.1 | 0.055 | 0.115 | Antihistaminic | 0.115 0.045 DBMET02396 | DBMET02396 | |
| 0.059 | 0.03 | 0.132 | Nicotinic receptor alpha7 subunit antagonist | 0.104 0.011 DBMET02396 0.084 0.016 DBMET00945 0.132 0.008 DBMET02395 | DBMET02395 | |
| 0.085 | 0.058 | 0.103 | Histamine antagonist | 0.103 0.046 DBMET02396 | DBMET02396 | |
| 0.083 | 0.057 | 0.146 | Estrogen-related receptor beta agonist | 0.083 0.058 DBMET02395 0.146 0.004 DB09269 | DB09269 | |
| 0.21 | 0.186 | 0.359 | Immunosuppressant | 0.359 0.082 DB09269 | DB09269 | |
| 0.087 | 0.064 | 0.393 | Triose-phosphate isomerase inhibitor | 0.125 0.03 DBMET02395 0.393 0.003 DB09269 | DB09269 | |
| 0.075 | 0.054 | 0.076 | Analgesic, opioid | 0.076 0.053 DBMET02395 | DBMET02395 | |
| 0.198 | 0.178 | 0.449 | Vasodilator, peripheral | 0.212 0.163 DBMET02396 0.269 0.114 DBMET02395 0.449 0.041 DB09269 | DB09269 | |
| 0.077 | 0.061 | 0.081 | Histamine H1 receptor antagonist | 0.081 0.056 DB09269 | DB09269 | |
| 0.088 | 0.074 | 0.244 | Creatine kinase inhibitor | 0.088 0.074 DBMET02396 0.213 0.009 DBMET02395 0.244 0.006 DB09269 | DB09269 | |
| 0.1 | 0.088 | 0.314 | Cholesterol synthesis inhibitor | 0.314 0.01 DB09269 | DB09269 | |
| 0.13 | 0.119 | 0.161 | Nitric oxide antagonist | 0.161 0.087 DB09269 | DB09269 | |
| 0.219 | 0.208 | 0.287 | Antibacterial | 0.287 0.146 DBMET02395 0.282 0.149 DB09269 | DBMET02395 | |
| 0.043 | 0.032 | 0.098 | Nicotinic receptor alpha3 subunit antagonist | 0.077 0.013 DBMET02396 0.043 0.031 DBMET00945 0.098 0.01 DBMET02395 | DBMET02395 | |
| 0.05 | 0.039 | 0.05 | Glucose-6-phosphate translocase inhibitor | |||
| 0.055 | 0.044 | 0.102 | Dopamine uptake inhibitor | 0.097 0.019 DBMET02396 0.086 0.023 DBMET00945 0.102 0.018 DBMET02395 | DBMET02395 | |
| 0.089 | 0.079 | 0.152 | Anabolic | 0.108 0.052 DBMET02396 0.129 0.032 DBMET00945 0.142 0.022 DBMET02395 0.152 0.017 DB09269 | DB09269 | |
| 0.051 | 0.041 | 0.072 | Acetylcholine M2 receptor agonist | 0.064 0.025 DBMET02396 0.058 0.032 DBMET00945 0.072 0.018 DBMET02395 | DBMET02395 | |
| 0.078 | 0.068 | 0.163 | Antineoplastic alkaloid | 0.098 0.049 DBMET02396 0.119 0.038 DBMET00945 0.163 0.024 DBMET02395 | DBMET02395 | |
| 0.034 | 0.025 | 0.041 | HMG CoA reductase inhibitor | 0.041 0.014 DBMET02395 0.038 0.017 DB09269 | DBMET02395 | |
| 0.051 | 0.043 | 0.088 | Myc inhibitor | 0.064 0.025 DBMET02396 0.058 0.033 DBMET00945 0.088 0.01 DBMET02395 | DBMET02395 | |
| 0.164 | 0.16 | 0.612 | 5 Hydroxytryptamine release stimulant | 0.426 0.041 DBMET02396 0.266 0.082 DBMET00945 0.465 0.033 DBMET02395 0.612 0.013 DB09269 | DB09269 | |
| 0.027 | 0.024 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 DBMET02396 0.035 0.007 DBMET02395 | DBMET02395 | |
| 0.033 | 0.031 | 0.058 | Nicotinic receptor beta4 subunit antagonist | 0.038 0.025 DBMET02396 0.058 0.013 DBMET02395 | DBMET02395 | |
| 0.18 | 0.18 | 0.396 | Gastrin inhibitor | 0.233 0.101 DBMET02396 0.204 0.144 DBMET02395 0.396 0.005 DB09269 | DB09269 | |
| 0.031 | 0.033 | 0.091 | 5-Alpha-reductase inhibitor | 0.034 0.03 DBMET00945 0.091 0.011 DB09269 | DB09269 | |
| 0.113 | 0.118 | 0.118 | Cholinergic | 0.118 0.111 DBMET02395 | DBMET02395 | |
| 0.021 | 0.03 | 0.034 | 5 Hydroxytryptamine 4 agonist | 0.023 0.019 DBMET02396 0.034 0.005 DBMET02395 | DBMET02395 | |
| 0.063 | 0.073 | 0.127 | Nicotinic alpha4beta2 receptor antagonist | 0.121 0.017 DBMET02396 0.103 0.029 DBMET00945 0.127 0.014 DBMET02395 0.068 0.064 DB09269 | DBMET02395 | |
| 0.045 | 0.059 | 0.096 | Nicotinic alpha3beta2 receptor antagonist | 0.067 0.019 DBMET02396 0.049 0.047 DBMET00945 0.096 0.008 DBMET02395 0.058 0.029 DB09269 | DBMET02395 | |
| 0.023 | 0.04 | 0.033 | Estrogen-related receptor gamma antagonist | 0.028 0.02 DBMET02395 0.033 0.011 DB09269 | DB09269 | |
| 0.081 | 0.098 | 0.177 | Bile acid receptor antagonist | 0.096 0.057 DBMET02396 0.107 0.036 DBMET02395 0.177 0.005 DB09269 | DB09269 | |
| 0.056 | 0.073 | 0.069 | Beta 2 adrenoreceptor agonist | 0.069 0.021 DB09269 | DB09269 | |
| 0.073 | 0.093 | 0.195 | Prolactin inhibitor | 0.117 0.04 DBMET02395 0.195 0.009 DB09269 | DB09269 | |
| 0.025 | 0.047 | 0.055 | Farnesoid X receptor agonist | 0.055 0.012 DBMET02395 0.051 0.014 DB09269 | DBMET02395 | |
| 0.037 | 0.061 | 0.119 | Glucose-6-phosphate isomerase inhibitor | 0.061 0.018 DBMET02395 0.119 0.004 DB09269 | DB09269 | |
| 0.012 | 0.036 | 0.052 | 5-Alpha-reductase 2 inhibitor | 0.052 0.007 DB09269 | DB09269 | |
| 0.013 | 0.039 | 0.027 | CXC chemokine 5 receptor antagonist | 0.027 0.005 DB09269 | DB09269 | |
| 0.088 | 0.115 | 0.158 | Microtubule formation inhibitor | 0.113 0.069 DBMET02396 0.125 0.055 DBMET02395 0.158 0.034 DB09269 | DB09269 | |
| 0.083 | 0.112 | 0.152 | Alkylator | 0.119 0.069 DBMET02396 0.152 0.046 DBMET02395 0.146 0.048 DB09269 | DBMET02395 | |
| 0.104 | 0.134 | 0.209 | Vanilloid 1 agonist | 0.12 0.087 DBMET02396 0.209 0.01 DB09269 | DB09269 | |
| 0.176 | 0.206 | 0.335 | Vasodilator, coronary | 0.241 0.143 DBMET02395 0.335 0.063 DB09269 | DB09269 | |
| 0.037 | 0.067 | 0.073 | Parathyroid hormone antagonist | 0.073 0.006 DBMET02395 | DBMET02395 | |
| 0.078 | 0.11 | 0.191 | Adenylate cyclase inhibitor | 0.13 0.059 DBMET02395 0.191 0.027 DB09269 | DB09269 | |
| 0.114 | 0.149 | 0.285 | Interferon gamma antagonist | 0.128 0.114 DBMET02396 0.156 0.07 DBMET02395 0.285 0.022 DB09269 | DB09269 | |
| 0.039 | 0.074 | 0.094 | Alpha-mannosidase inhibitor | 0.076 0.013 DBMET02395 0.094 0.007 DB09269 | DB09269 | |
| 0.008 | 0.044 | 0.027 | 5-Alpha-reductase 1 inhibitor | 0.027 0.009 DB09269 | DB09269 | |
| 0.118 | 0.156 | 0.204 | Hepatoprotectant | 0.158 0.102 DBMET02395 0.204 0.063 DB09269 | DB09269 | |
| 0.113 | 0.153 | 0.314 | Platelet adhesion inhibitor | 0.314 0.03 DB09269 | DB09269 | |
| 0.014 | 0.054 | 0.057 | Prostaglandin F2 alpha agonist | 0.057 0.004 DB09269 | DB09269 | |
| 0.023 | 0.064 | 0.038 | Estrogen-related receptor beta antagonist | 0.038 0.013 DBMET00945 | DBMET00945 | |
| 0.011 | 0.054 | 0.032 | RNA-directed RNA polymerase stimulant | 0.032 0.02 DBMET02395 | DBMET02395 | |
| 0.01 | 0.053 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 DB09269 | DB09269 | |
| 0.035 | 0.081 | 0.066 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.044 DBMET02396 0.066 0.019 DBMET02395 | DBMET02395 | |
| 0.009 | 0.057 | 0.02 | Telomerase stimulant | 0.019 0.009 DBMET02395 0.02 0.007 DB09269 | DB09269 | |
| 0.092 | 0.14 | 0.222 | Protein kinase stimulant | 0.11 0.104 DBMET02395 0.222 0.034 DB09269 | DB09269 | |
| 0.012 | 0.06 | 0.024 | Antibiotic Anthracycline-like | 0.019 0.013 DBMET02395 0.024 0.006 DB09269 | DB09269 | |
| 0.044 | 0.093 | 0.318 | Catalase inhibitor | 0.318 0.005 DB09269 | DB09269 | |
| 0.046 | 0.095 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 DBMET02395 0.097 0.035 DB09269 | DBMET02395 | |
| 0.193 | 0.246 | 0.227 | Analgesic | 0.227 0.206 DB09269 | DB09269 | |
| 0.13 | 0.185 | 0.476 | Interleukin agonist | 0.222 0.101 DBMET02396 0.288 0.054 DBMET02395 0.476 0.01 DB09269 | DB09269 | |
| 0.163 | 0.218 | 0.598 | Tyrosine 3 hydroxylase inhibitor | 0.227 0.094 DBMET02396 0.243 0.075 DBMET02395 0.598 0.003 DB09269 | DB09269 | |
| 0.077 | 0.133 | 0.333 | Cyclooxygenase 1 inhibitor | 0.333 0.011 DB09269 | DB09269 | |
| 0.017 | 0.076 | 0.053 | 5 Hydroxytryptamine 3B antagonist | 0.052 0.014 DBMET02396 0.04 0.021 DBMET00945 0.053 0.013 DBMET02395 | DBMET02395 | |
| 0.028 | 0.087 | 0.047 | Protein 50S ribosomal subunit inhibitor | 0.047 0.043 DBMET02396 | DBMET02396 | |
| 0.082 | 0.14 | 0.133 | Acetylcholine release stimulant | 0.104 0.078 DBMET02396 0.133 0.03 DB09269 | DB09269 | |
| 0.004 | 0.064 | 0.02 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DB09269 | DB09269 | |
| 0.065 | 0.125 | 0.286 | UDP-glucose 4-epimerase inhibitor | 0.131 0.036 DBMET02395 0.286 0.011 DB09269 | DB09269 | |
| 0.036 | 0.097 | 0.263 | Phosphofructokinase-1 inhibitor | 0.095 0.034 DBMET02395 0.263 0.007 DB09269 | DB09269 | |
| 0.1 | 0.162 | 0.321 | Growth hormone agonist | 0.125 0.113 DBMET02396 0.128 0.11 DBMET00945 0.321 0.028 DB09269 | DB09269 | |
| 0.021 | 0.085 | 0.08 | p53 inhibitor | 0.08 0.004 DB09269 | DB09269 | |
| 0.105 | 0.168 | 0.18 | Pyruvate kinase inhibitor | 0.18 0.093 DB09269 | DB09269 | |
| 0.037 | 0.101 | 0.078 | Adrenaline uptake inhibitor | 0.055 0.05 DBMET02396 0.054 0.053 DBMET00945 0.078 0.028 DBMET02395 | DBMET02395 | |
| 0.014 | 0.081 | 0.066 | Lysophosphatidic acid receptor 1 agonist | 0.066 0.003 DB09269 | DB09269 | |
| 0.024 | 0.091 | 0.088 | Mannosidase inhibitor | 0.059 0.017 DBMET02395 0.088 0.007 DB09269 | DB09269 | |
| 0.06 | 0.128 | 0.134 | Sphingomyelinase inhibitor | 0.083 0.082 DBMET02396 0.106 0.054 DBMET02395 0.134 0.032 DB09269 | DB09269 | |
| 0.032 | 0.101 | 0.207 | Carbamoyl phosphate synthetase inhibitor | 0.096 0.022 DBMET02395 0.207 0.007 DB09269 | DB09269 | |
| 0.034 | 0.103 | 0.092 | Androgen agonist | 0.053 0.051 DBMET02396 0.092 0.018 DBMET02395 0.071 0.03 DB09269 | DBMET02395 | |
| 0.005 | 0.078 | 0.018 | Ileal bile acid transport inhibitor | 0.018 0.01 DB09269 | DB09269 | |
| 0.009 | 0.084 | 0.094 | Glutamate (mGluR1a) agonist | 0.094 0.004 DB09269 | DB09269 | |
| 0.009 | 0.086 | 0.024 | Estrogen-related receptor gamma agonist | 0.024 0.006 DB09269 | DB09269 | |
| 0.124 | 0.201 | 0.252 | Antioxidant | 0.252 0.082 DB09269 | DB09269 | |
| 0.005 | 0.083 | 0.021 | Prostacyclin agonist | 0.021 0.008 DB09269 | DB09269 | |
| 0.003 | 0.081 | 0.024 | Thromboxane agonist | 0.024 0.003 DB09269 | DB09269 | |
| 0.042 | 0.12 | 0.222 | Aminopeptidase I inhibitor | 0.222 0.005 DB09269 | DB09269 | |
| 0.015 | 0.095 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.009 DB09269 | DB09269 | |
| 0.02 | 0.101 | 0.035 | Elastase 2B inhibitor | 0.035 0.013 DB09269 | DB09269 | |
| 0.02 | 0.101 | 0.035 | Elastase 3B inhibitor | 0.035 0.013 DB09269 | DB09269 | |
| 0.02 | 0.101 | 0.035 | Elastase 3A inhibitor | 0.035 0.013 DB09269 | DB09269 | |
| 0.031 | 0.117 | 0.05 | Squalene epoxidase inhibitor | 0.05 0.034 DB09269 | DB09269 | |
| 0.114 | 0.199 | 0.4 | Succinate dehydrogenase inhibitor | 0.4 0.004 DB09269 | DB09269 | |
| 0.112 | 0.199 | 0.329 | Immunostimulant | 0.177 0.135 DBMET02396 0.212 0.113 DBMET02395 0.329 0.071 DB09269 | DB09269 | |
| 0.008 | 0.096 | 0.018 | Integrin beta6 antagonist | 0.018 0.005 DB09269 | DB09269 | |
| 0.112 | 0.2 | 0.605 | Platelet antagonist | 0.605 0.006 DB09269 | DB09269 | |
| 0.01 | 0.1 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.025 0.01 DB09269 | DB09269 | |
| 0.006 | 0.096 | 0.03 | Thromboxane A2 agonist | 0.03 0.003 DB09269 | DB09269 | |
| 0.021 | 0.112 | 0.033 | Tubulin agonist | 0.033 0.027 DBMET02395 | DBMET02395 | |
| 0.013 | 0.104 | 0.041 | Vanilloid 2 agonist | 0.027 0.013 DBMET02395 0.041 0.004 DB09269 | DB09269 | |
| 0.005 | 0.097 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 DB09269 | DB09269 | |
| 0.01 | 0.104 | 0.125 | Retinoid X receptor agonist | 0.125 0.003 DB09269 | DB09269 | |
| 0.015 | 0.11 | 0.061 | Acetylcholine M1 receptor agonist | 0.041 0.031 DBMET02396 0.061 0.021 DBMET02395 | DBMET02395 | |
| 0.018 | 0.114 | 0.067 | Guanylate cyclase inhibitor | 0.045 0.027 DBMET02395 0.067 0.006 DB09269 | DB09269 | |
| 0.01 | 0.107 | 0.059 | Lysine carboxypeptidase inhibitor | 0.059 0.006 DB09269 | DB09269 | |
| 0.018 | 0.116 | 0.041 | Carboxypeptidase B inhibitor | 0.041 0.012 DB09269 | DB09269 | |
| 0.012 | 0.111 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 DB09269 | DB09269 | |
| 0.024 | 0.125 | 0.594 | Alcohol oxidase inhibitor | 0.105 0.017 DBMET02395 0.594 0.003 DB09269 | DB09269 | |
| 0.035 | 0.138 | 0.065 | Angiotensin-converting enzyme inhibitor | 0.065 0.024 DB09269 | DB09269 | |
| 0.1 | 0.203 | 0.244 | Anticonvulsant | 0.244 0.059 DB09269 | DB09269 | |
| 0.007 | 0.111 | 0.059 | Thyroid hormone alpha agonist | 0.059 0.003 DB09269 | DB09269 | |
| 0.046 | 0.149 | 0.15 | Glutamate (mGluR6) antagonist | 0.064 0.054 DBMET02395 0.15 0.004 DB09269 | DB09269 | |
| 0.026 | 0.129 | 0.094 | 5 Hydroxytryptamine 3 antagonist | 0.083 0.023 DBMET02396 0.066 0.031 DBMET00945 0.094 0.019 DBMET02395 | DBMET02395 | |
| 0.011 | 0.115 | 0.035 | Retinoid X beta receptor antagonist | 0.035 0.004 DB09269 | DB09269 | |
| 0.016 | 0.121 | 0.046 | Opioid kappa receptor agonist | 0.04 0.034 DBMET02396 0.046 0.027 DBMET02395 | DBMET02395 | |
| 0.004 | 0.11 | 0.014 | Integrin beta2 antagonist | 0.014 0.008 DB09269 | DB09269 | |
| 0.007 | 0.113 | 0.069 | Squalene synthetase inhibitor | 0.069 0.01 DB09269 | DB09269 | |
| 0.055 | 0.163 | 0.419 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.082 0.077 DBMET02395 0.419 0.004 DB09269 | DB09269 | |
| 0.107 | 0.215 | 0.25 | ATPase inhibitor | 0.148 0.106 DBMET02395 0.25 0.014 DB09269 | DB09269 | |
| 0.018 | 0.127 | 0.069 | Membrane dipeptidase inhibitor | 0.069 0.007 DB09269 | DB09269 | |
| 0.01 | 0.119 | 0.061 | Prostaglandin D2 agonist | 0.061 0.005 DB09269 | DB09269 | |
| 0.044 | 0.154 | 0.15 | Interferon agonist | 0.073 0.064 DBMET02395 0.15 0.01 DB09269 | DB09269 | |
| 0.058 | 0.17 | 0.159 | DNA polymerase I inhibitor | 0.159 0.044 DB09269 | DB09269 | |
| 0.047 | 0.159 | 0.101 | Opioid kappa receptor antagonist | 0.075 0.067 DBMET02396 0.101 0.034 DBMET02395 | DBMET02395 | |
| 0.018 | 0.131 | 0.054 | Glutamate (mGluR3) agonist | 0.054 0.004 DB09269 | DB09269 | |
| 0.086 | 0.2 | 0.126 | DNA repair enzyme inhibitor | 0.124 0.065 DBMET02395 0.126 0.061 DB09269 | DB09269 | |
| 0.026 | 0.14 | 0.292 | Aconitate hydratase inhibitor | 0.292 0.002 DB09269 | DB09269 | |
| 0.011 | 0.126 | 0.034 | AMPA receptor agonist | 0.034 0.026 DB09269 | DB09269 | |
| 0.01 | 0.126 | 0.027 | Neuraminidase (Influenza B) inhibitor | 0.027 0.006 DB09269 | DB09269 | |
| 0.123 | 0.24 | 0.504 | Superoxide dismutase inhibitor | 0.167 0.16 DBMET02395 0.504 0.013 DB09269 | DB09269 | |
| 0.016 | 0.134 | 0.133 | Ornithine carbamoyltransferase inhibitor | 0.133 0.011 DB09269 | DB09269 | |
| 0.011 | 0.129 | 0.031 | LFA antagonist | 0.031 0.014 DB09269 | DB09269 | |
| 0.091 | 0.211 | 0.216 | Adenylate cyclase stimulant | 0.149 0.065 DBMET02395 0.216 0.008 DB09269 | DB09269 | |
| 0.006 | 0.131 | 0.016 | Purinergic P2Y1 agonist | 0.014 0.013 DBMET02395 0.016 0.01 DB09269 | DB09269 | |
| 0.009 | 0.135 | 0.02 | Retinoic acid beta receptor agonist | 0.02 0.014 DB09269 | DB09269 | |
| 0.008 | 0.135 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DB09269 | DB09269 | |
| 0.025 | 0.156 | 0.049 | HCV NS3/NS4A protease inhibitor | 0.049 0.035 DB09269 | DB09269 | |
| 0.004 | 0.135 | 0.142 | Free fatty acid receptor 1 agonist | 0.142 0.004 DB09269 | DB09269 | |
| 0.095 | 0.228 | 0.439 | Non-steroidal antiinflammatory agent | 0.439 0.01 DB09269 | DB09269 | |
| 0.02 | 0.155 | 0.231 | Argininosuccinate synthase inhibitor | 0.067 0.032 DBMET02395 0.231 0.006 DB09269 | DB09269 | |
| 0.016 | 0.151 | 0.039 | Ceramide glucosyltransferase inhibitor | 0.039 0.019 DBMET02395 0.039 0.019 DB09269 | DB09269 | |
| 0.059 | 0.194 | 0.159 | Nav1.4 sodium channel blocker | 0.159 0.03 DB09269 | DB09269 | |
| 0.006 | 0.144 | 0.029 | Acetylcholine M4 receptor agonist | 0.029 0.023 DBMET02395 | DBMET02395 | |
| 0.01 | 0.15 | 0.196 | Fumarate hydratase inhibitor | 0.196 0.003 DB09269 | DB09269 | |
| 0.038 | 0.179 | 0.268 | Glutamate dehydrogenase inhibitor | 0.082 0.043 DBMET02395 0.268 0.006 DB09269 | DB09269 | |
| 0.015 | 0.156 | 0.19 | Glutamate (mGluR3) antagonist | 0.19 0.004 DB09269 | DB09269 | |
| 0.027 | 0.17 | 0.052 | Beta adrenoreceptor agonist | 0.052 0.014 DB09269 | DB09269 | |
| 0.017 | 0.159 | 0.044 | Retinoic acid alpha receptor agonist | 0.044 0.02 DB09269 | DB09269 | |
| 0.037 | 0.183 | 0.14 | Ornithine decarboxylase inhibitor | 0.14 0.014 DB09269 | DB09269 | |
| 0.018 | 0.165 | 0.176 | Acyl-CoA dehydrogenase inhibitor | 0.068 0.028 DBMET02395 0.176 0.007 DB09269 | DB09269 | |
| 0.01 | 0.157 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DB09269 | DB09269 | |
| 0.004 | 0.151 | 0.068 | Arginase inhibitor | 0.068 0.008 DB09269 | DB09269 | |
| 0.017 | 0.165 | 0.063 | Retinoid X alpha receptor antagonist | 0.063 0.004 DB09269 | DB09269 | |
| 0.007 | 0.155 | 0.05 | Integrin beta5 antagonist | 0.05 0.005 DB09269 | DB09269 | |
| 0.115 | 0.264 | 0.305 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.305 0.022 DB09269 | DB09269 | |
| 0.052 | 0.203 | 0.096 | mTOR complex 2 inhibitor | 0.096 0.038 DBMET02395 | DBMET02395 | |
| 0.035 | 0.187 | 0.117 | Interferon inducer | 0.117 0.008 DB09269 | DB09269 | |
| 0.024 | 0.176 | 0.122 | Glutamate (mGluR group III) antagonist | 0.122 0.004 DB09269 | DB09269 | |
| 0.086 | 0.237 | 0.21 | Melanin inhibitor | 0.21 0.037 DB09269 | DB09269 | |
| 0.002 | 0.156 | 0.027 | Glutamate (mGluR6) agonist | 0.027 0.003 DB09269 | DB09269 | |
| 0.141 | 0.295 | 0.32 | Apoptosis antagonist | 0.202 0.176 DBMET02396 0.32 0.073 DB09269 | DB09269 | |
| 0.018 | 0.172 | 0.072 | Retinoid X receptor antagonist | 0.072 0.004 DB09269 | DB09269 | |
| 0.027 | 0.181 | 0.063 | Epithelial sodium channel blocker | 0.063 0.024 DB09269 | DB09269 | |
| 0.011 | 0.166 | 0.037 | Calcitonin receptor agonist | 0.037 0.022 DB09269 | DB09269 | |
| 0.03 | 0.186 | 0.1 | Phospholipase D inhibitor | 0.092 0.02 DBMET02395 0.1 0.014 DB09269 | DB09269 | |
| 0.006 | 0.162 | 0.102 | Retinoid X gamma receptor agonist | 0.102 0.004 DB09269 | DB09269 | |
| 0.12 | 0.277 | 0.306 | DNA synthesis inhibitor | 0.258 0.062 DBMET02395 0.306 0.041 DB09269 | DB09269 | |
| 0.014 | 0.171 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.026 0.021 DB09269 | DB09269 | |
| 0.022 | 0.18 | 0.121 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.035 DBMET02395 0.121 0.011 DB09269 | DB09269 | |
| 0.025 | 0.183 | 0.088 | Sphingosine kinase 2 inhibitor | 0.088 0.011 DBMET02395 0.07 0.021 DB09269 | DBMET02395 | |
| 0.085 | 0.243 | 0.239 | Interleukin 6 antagonist | 0.239 0.025 DB09269 | DB09269 | |
| 0.009 | 0.168 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.02 DB09269 | DB09269 | |
| 0.073 | 0.237 | 0.176 | Farnesoid X receptor antagonist | 0.124 0.095 DBMET02395 0.176 0.031 DB09269 | DB09269 | |
| 0.019 | 0.183 | 0.064 | Glutamate (mGluR8) antagonist | 0.064 0.005 DB09269 | DB09269 | |
| 0.043 | 0.208 | 0.059 | Prolactin release inhibitor | 0.059 0.057 DBMET02395 | DBMET02395 | |
| 0.005 | 0.171 | 0.11 | Retinoid X beta receptor agonist | 0.11 0.003 DB09269 | DB09269 | |
| 0.023 | 0.19 | 0.127 | Glutamate (mGluR4) antagonist | 0.127 0.004 DB09269 | DB09269 | |
| 0.005 | 0.174 | 0.182 | GP IIb/IIIa receptor antagonist | 0.182 0.008 DB09269 | DB09269 | |
| 0.011 | 0.181 | 0.093 | Glutamate (mGluR1) agonist | 0.093 0.004 DB09269 | DB09269 | |
| 0.043 | 0.213 | 0.298 | Cell adhesion molecule inhibitor | 0.298 0.005 DB09269 | DB09269 | |
| 0.007 | 0.178 | 0.052 | Leukotriene B4 receptor 2 antagonist | 0.052 0.004 DB09269 | DB09269 | |
| 0.015 | 0.187 | 0.033 | Hedgehog signaling activator | 0.033 0.009 DBMET02395 0.03 0.013 DB09269 | DBMET02395 | |
| 0.026 | 0.199 | 0.532 | Glutamate decarboxylase inhibitor | 0.532 0.002 DB09269 | DB09269 | |
| 0.078 | 0.252 | 0.451 | Insulin secretagoues | 0.451 0.005 DB09269 | DB09269 | |
| 0.046 | 0.22 | 0.114 | MDM2 inhibitor | 0.114 0.004 DB09269 | DB09269 | |
| 0.026 | 0.201 | 0.089 | Bombesin 2 receptor antagonist | 0.089 0.015 DB09269 | DB09269 | |
| 0.009 | 0.186 | 0.036 | Nicotinic acid receptor 2 agonist | 0.036 0.024 DB09269 | DB09269 | |
| 0.019 | 0.196 | 0.033 | Adenosine uptake inhibitor | 0.033 0.029 DBMET02395 | DBMET02395 | |
| 0.05 | 0.228 | 0.338 | ABCA1 expression enhancer | 0.338 0.005 DB09269 | DB09269 | |
| 0.015 | 0.192 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET02395 0.028 0.015 DB09269 | DB09269 | |
| 0.007 | 0.185 | 0.055 | Carnitine palmitoyltransferase 1A inhibitor | 0.055 0.006 DB09269 | DB09269 | |
| 0.012 | 0.191 | 0.045 | Toll-Like receptor 2 agonist | 0.045 0.026 DB09269 | DB09269 | |
| 0.003 | 0.183 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 DBMET02395 | DBMET02395 | |
| 0.058 | 0.24 | 0.37 | Adenylate kinase inhibitor | 0.117 0.046 DBMET02395 0.37 0.004 DB09269 | DB09269 | |
| 0.078 | 0.261 | 0.668 | Aldehyde oxidase inhibitor | 0.178 0.118 DBMET02395 0.668 0.011 DB09269 | DB09269 | |
| 0.047 | 0.229 | 0.228 | NADH dehydrogenase inhibitor | 0.102 0.042 DBMET02395 0.228 0.009 DB09269 | DB09269 | |
| 0.035 | 0.218 | 0.265 | Aminopeptidase B inhibitor | 0.265 0.011 DB09269 | DB09269 | |
| 0.005 | 0.189 | 0.016 | Angiotensin-converting enzyme 2 inhibitor | 0.016 0.015 DB09269 | DB09269 | |
| 0.035 | 0.22 | 0.084 | Opioid antagonist | 0.084 0.064 DBMET02395 | DBMET02395 | |
| 0.005 | 0.191 | 0.019 | Retinoic acid alpha receptor antagonist | 0.019 0.016 DB09269 | DB09269 | |
| 0.001 | 0.189 | 0.013 | Integrin alpha5beta6 antagonist | 0.013 0.003 DB09269 | DB09269 | |
| 0.03 | 0.218 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | 0.091 0.02 DB09269 | DB09269 | |
| 0.048 | 0.236 | 0.16 | Lanosterol 14 alpha demethylase inhibitor | 0.113 0.038 DBMET02395 0.16 0.009 DB09269 | DB09269 | |
| 0.005 | 0.194 | 0.055 | Uridine phosphorylase inhibitor | 0.055 0.007 DB09269 | DB09269 | |
| 0.018 | 0.208 | 0.049 | Thymidine kinase inhibitor | 0.049 0.02 DB09269 | DB09269 | |
| 0.02 | 0.211 | 0.119 | Kainate receptor agonist | 0.038 0.037 DBMET02395 0.119 0.002 DB09269 | DB09269 | |
| 0.041 | 0.232 | 0.346 | Cystathionine beta-synthase inhibitor | 0.346 0.007 DB09269 | DB09269 | |
| 0.051 | 0.245 | 0.346 | Vanilloid agonist | 0.346 0.004 DBMET00945 0.132 0.014 DB09269 | DBMET00945 | |
| 0.009 | 0.203 | 0.035 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DB09269 | DB09269 | |
| 0.003 | 0.196 | 0.029 | Carbonic anhydrase X inhibitor | 0.029 0.004 DB09269 | DB09269 | |
| 0.003 | 0.196 | 0.029 | Carbonic anhydrase VIII inhibitor | 0.029 0.004 DB09269 | DB09269 | |
| 0.007 | 0.201 | 0.032 | Integrin alphaVbeta1 antagonist | 0.032 0.005 DB09269 | DB09269 | |
| 0.002 | 0.197 | 0.041 | Aminopeptidase A inhibitor | 0.041 0.004 DB09269 | DB09269 | |
| 0.009 | 0.203 | 0.151 | Retinoid X alpha receptor agonist | 0.151 0.003 DB09269 | DB09269 | |
| 0.008 | 0.205 | 0.022 | Caspase 8 inhibitor | 0.022 0.009 DB09269 | DB09269 | |
| 0.011 | 0.209 | 0.134 | Thromboxane A2 antagonist | 0.134 0.004 DB09269 | DB09269 | |
| 0.018 | 0.216 | 0.095 | Glutamate (mGluR8) agonist | 0.095 0.003 DB09269 | DB09269 | |
| 0.012 | 0.21 | 0.062 | Glycine transporter 2 inhibitor | 0.062 0.024 DB09269 | DB09269 | |
| 0.011 | 0.211 | 0.093 | Dopamine D5 agonist | 0.039 0.029 DBMET02395 0.093 0.005 DB09269 | DB09269 | |
| 0.021 | 0.223 | 0.404 | Phenylalanine 4-hydroxylase inhibitor | 0.404 0.003 DB09269 | DB09269 | |
| 0.003 | 0.206 | 0.027 | Neutral endopeptidase inhibitor | 0.027 0.013 DB09269 | DB09269 | |
| 0.011 | 0.214 | 0.087 | GABA uptake inhibitor | 0.087 0.004 DB09269 | DB09269 | |
| 0.006 | 0.211 | 0.103 | Free fatty acid receptor 1 antagonist | 0.103 0.003 DB09269 | DB09269 | |
| 0.03 | 0.24 | 0.128 | Glycine receptor antagonist | 0.082 0.054 DBMET02395 0.128 0.014 DB09269 | DB09269 | |
| 0.026 | 0.236 | 0.105 | Calcium antagonist | 0.105 0.045 DB09269 | DB09269 | |
| 0.01 | 0.222 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DB09269 | DB09269 | |
| 0.013 | 0.225 | 0.076 | Adenosine deaminase inhibitor | 0.041 0.039 DBMET02395 0.076 0.011 DB09269 | DB09269 | |
| 0.022 | 0.234 | 0.072 | Sphingosine kinase inhibitor | 0.072 0.022 DBMET02395 0.069 0.026 DB09269 | DBMET02395 | |
| 0.032 | 0.244 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.032 DB09269 | DB09269 | |
| 0.041 | 0.254 | 0.074 | Calcium channel P-type blocker | 0.074 0.021 DB09269 | DB09269 | |
| 0.08 | 0.295 | 0.192 | Vasodilator | 0.167 0.135 DBMET02396 0.192 0.111 DB09269 | DB09269 | |
| 0.016 | 0.231 | 0.282 | Biliverdin reductase inhibitor | 0.282 0.004 DB09269 | DB09269 | |
| 0.006 | 0.222 | 0.115 | Prostacyclin antagonist | 0.115 0.004 DB09269 | DB09269 | |
| 0.011 | 0.227 | 0.044 | Potassium channel Kv1.3 blocker | 0.044 0.036 DB09269 | DB09269 | |
| 0.005 | 0.222 | 0.034 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.034 0.014 DB09269 | DB09269 | |
| 0.003 | 0.22 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DB09269 | DB09269 | |
| 0.147 | 0.365 | 0.719 | Cyclophilin D inhibitor | 0.719 0.012 DB09269 | DB09269 | |
| 0.01 | 0.228 | 0.063 | Integrin alpha5beta1 antagonist | 0.063 0.01 DB09269 | DB09269 | |
| 0.013 | 0.231 | 0.146 | Thromboxane antagonist | 0.146 0.005 DB09269 | DB09269 | |
| 0.009 | 0.228 | 0.077 | ATP citrate lysase inhibitor | 0.077 0.004 DB09269 | DB09269 | |
| 0.035 | 0.254 | 0.187 | Keratolytic | 0.187 0.009 DB09269 | DB09269 | |
| 0.006 | 0.227 | 0.066 | Antimetabolite | 0.066 0.023 DB09269 | DB09269 | |
| 0.007 | 0.23 | 0.069 | Ribonucleoside-diphosphate reductase inhibitor | 0.069 0.029 DB09269 | DB09269 | |
| 0.053 | 0.278 | 0.398 | Cell adhesion inhibitor | 0.398 0.005 DB09269 | DB09269 | |
| 0.007 | 0.233 | 0.071 | Ribonucleotide reductase inhibitor | 0.071 0.031 DB09269 | DB09269 | |
| 0.053 | 0.28 | 0.078 | T cell inhibitor | 0.078 0.075 DB09269 | DB09269 | |
| 0.005 | 0.234 | 0.035 | G protein-coupled receptor agonist | 0.035 0.029 DB09269 | DB09269 | |
| 0.002 | 0.233 | 0.132 | Prostaglandin EP4 agonist | 0.132 0.003 DB09269 | DB09269 | |
| 0.042 | 0.273 | 0.32 | Amylase inhibitor | 0.103 0.094 DBMET02395 0.32 0.016 DB09269 | DB09269 | |
| 0.002 | 0.235 | 0.013 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.013 0.012 DB09269 | DB09269 | |
| 0.036 | 0.269 | 0.715 | GABA C receptor agonist | 0.114 0.054 DBMET02395 0.715 0.002 DB09269 | DB09269 | |
| 0.014 | 0.25 | 0.121 | Lysophosphatidic acid 3 receptor antagonist | 0.121 0.004 DB09269 | DB09269 | |
| 0.035 | 0.273 | 0.269 | HIV-1 integrase (Overall Integration) inhibitor | 0.269 0.004 DB09269 | DB09269 | |
| 0.05 | 0.288 | 0.256 | Photosensitizer | 0.256 0.005 DB09269 | DB09269 | |
| 0.013 | 0.252 | 0.042 | Erythropoietin receptor agonist | 0.042 0.027 DB09269 | DB09269 | |
| 0.002 | 0.241 | 0.027 | Integrin alpha4beta1 antagonist | 0.027 0.008 DB09269 | DB09269 | |
| 0.015 | 0.257 | 0.16 | Selectin antagonist | 0.16 0.016 DB09269 | DB09269 | |
| 0.032 | 0.275 | 0.082 | Caspase 9 inhibitor | 0.082 0.022 DB09269 | DB09269 | |
| 0.025 | 0.269 | 0.208 | GABA aminotransferase inhibitor | 0.208 0.004 DB09269 | DB09269 | |
| 0.022 | 0.268 | 0.123 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.123 0.028 DB09269 | DB09269 | |
| 0.003 | 0.254 | 0.062 | Prostaglandin EP2 agonist | 0.062 0.004 DB09269 | DB09269 | |
| 0.004 | 0.256 | 0.045 | Integrin beta3 antagonist | 0.045 0.007 DB09269 | DB09269 | |
| 0.084 | 0.336 | 0.477 | Hypoglycemic | 0.477 0.017 DB09269 | DB09269 | |
| 0.116 | 0.369 | 0.589 | Histamine release inhibitor | 0.589 0.011 DB09269 | DB09269 | |
| 0.025 | 0.279 | 0.117 | Adrenaline agonist | 0.117 0.027 DB09269 | DB09269 | |
| 0.005 | 0.26 | 0.038 | Integrin alphaVbeta3 antagonist | 0.038 0.005 DB09269 | DB09269 | |
| 0.059 | 0.316 | 0.272 | DNA methyltransferase I inhibitor | 0.272 0.037 DB09269 | DB09269 | |
| 0.001 | 0.258 | 0.014 | Integrin alphaVbeta5 antagonist | 0.014 0.005 DB09269 | DB09269 | |
| 0.027 | 0.285 | 0.097 | Protease inhibitor | 0.097 0.068 DB09269 | DB09269 | |
| 0.005 | 0.262 | 0.155 | Prostaglandin agonist | 0.155 0.004 DB09269 | DB09269 | |
| 0.006 | 0.264 | 0.065 | Carnitine palmitoyltransferase 1 inhibitor | 0.065 0.004 DB09269 | DB09269 | |
| 0.004 | 0.263 | 0.163 | Integrin alpha4 antagonist | 0.163 0.004 DB09269 | DB09269 | |
| 0.006 | 0.266 | 0.068 | Carnitine palmitoyltransferase inhibitor | 0.068 0.004 DB09269 | DB09269 | |
| 0.026 | 0.286 | 0.106 | HIV-1 integrase inhibitor | 0.106 0.022 DB09269 | DB09269 | |
| 0.028 | 0.291 | 0.157 | Mediator release inhibitor | 0.157 0.026 DB09269 | DB09269 | |
| 0.005 | 0.269 | 0.058 | Complement C3a chemotactic receptor antagonist | 0.058 0.023 DB09269 | DB09269 | |
| 0.005 | 0.269 | 0.333 | Integrin antagonist | 0.333 0.005 DB09269 | DB09269 | |
| 0.003 | 0.266 | 0.059 | Prostaglandin H2 antagonist | 0.059 0.003 DB09269 | DB09269 | |
| 0.016 | 0.283 | 0.124 | Leukotriene B4 antagonist | 0.124 0.007 DB09269 | DB09269 | |
| 0.018 | 0.288 | 0.203 | Sphingosine 1-phosphate receptor 5 agonist | 0.203 0.004 DB09269 | DB09269 | |
| 0.004 | 0.275 | 0.264 | Thyroid hormone alpha antagonist | 0.264 0.002 DB09269 | DB09269 | |
| 0.041 | 0.312 | 0.134 | Granulocyte macrophage colony stimulating factor agonist | 0.134 0.009 DB09269 | DB09269 | |
| 0.006 | 0.28 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DB09269 | DB09269 | |
| 0.009 | 0.283 | 0.106 | Macrophage elastase inhibitor | 0.106 0.009 DB09269 | DB09269 | |
| 0.007 | 0.281 | 0.151 | Peroxisome proliferator-activated receptor alpha agonist | 0.151 0.006 DB09269 | DB09269 | |
| 0.024 | 0.299 | 0.129 | Glutamate (mGluR7) antagonist | 0.129 0.004 DB09269 | DB09269 | |
| 0.004 | 0.281 | 0.052 | Sphingosine 1-phosphate receptor 3 agonist | 0.052 0.015 DB09269 | DB09269 | |
| 0.036 | 0.314 | 0.094 | Vanilloid 4 agonist | 0.094 0.022 DB09269 | DB09269 | |
| 0.028 | 0.306 | 0.072 | Ryanodine receptor antagonist | 0.072 0.015 DB09269 | DB09269 | |
| 0.054 | 0.332 | 0.139 | Folate antagonist | 0.139 0.027 DB09269 | DB09269 | |
| 0.014 | 0.293 | 0.079 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DB09269 | DB09269 | |
| 0.039 | 0.318 | 0.115 | Neurotrophic factor | 0.115 0.104 DB09269 | DB09269 | |
| 0.046 | 0.325 | 0.133 | Glutamate (mGluR7) agonist | 0.133 0.02 DB09269 | DB09269 | |
| 0.002 | 0.283 | 0.108 | Peroxisome proliferator-activated receptor alpha antagonist | 0.108 0.004 DB09269 | DB09269 | |
| 0.012 | 0.297 | 0.044 | Sphingosine kinase 1 inhibitor | 0.041 0.03 DBMET02395 0.044 0.024 DB09269 | DB09269 | |
| 0.095 | 0.381 | 0.255 | RNA-directed DNA polymerase inhibitor | 0.192 0.112 DBMET02395 0.255 0.046 DB09269 | DB09269 | |
| 0.002 | 0.289 | 0.066 | G-protein-coupled receptor 120 agonist | 0.066 0.003 DB09269 | DB09269 | |
| 0.072 | 0.361 | 0.341 | Cyclic AMP phosphodiesterase inhibitor | 0.341 0.028 DB09269 | DB09269 | |
| 0.07 | 0.36 | 0.303 | Neurotrophic factor enhancer | 0.303 0.017 DB09269 | DB09269 | |
| 0.006 | 0.296 | 0.027 | Urotensin II agonist | 0.027 0.018 DB09269 | DB09269 | |
| 0.045 | 0.337 | 0.269 | Diuretic | 0.118 0.107 DBMET02395 0.269 0.028 DB09269 | DB09269 | |
| 0.018 | 0.311 | 0.049 | Aldosterone antagonist | 0.049 0.03 DB09269 | DB09269 | |
| 0.006 | 0.3 | 0.06 | Lysophosphatidic acid 1 receptor antagonist | 0.06 0.003 DB09269 | DB09269 | |
| 0.011 | 0.306 | 0.385 | Peroxisome proliferator-activated receptor gamma agonist | 0.385 0.004 DB09269 | DB09269 | |
| 0.004 | 0.302 | 0.041 | HCV NS5B polymerase inhibitor | 0.041 0.014 DB09269 | DB09269 | |
| 0.06 | 0.358 | 0.183 | Hemostatic | 0.183 0.041 DB09269 | DB09269 | |
| 0.065 | 0.364 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.072 DB09269 | DB09269 | |
| 0.011 | 0.311 | 0.07 | Cyclin-dependent kinase 6 inhibitor | 0.07 0.031 DBMET02395 | DBMET02395 | |
| 0.017 | 0.318 | 0.038 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.014 DB09269 | DB09269 | |
| 0.055 | 0.36 | 0.279 | DNA methylase inhibitor | 0.279 0.035 DB09269 | DB09269 | |
| 0.057 | 0.363 | 0.159 | Antipruritic | 0.135 0.114 DBMET02395 0.159 0.085 DB09269 | DB09269 | |
| 0.02 | 0.325 | 0.101 | Elastase 1 inhibitor | 0.101 0.019 DB09269 | DB09269 | |
| 0.001 | 0.308 | 0.032 | Thyroid hormone beta agonist | 0.032 0.003 DB09269 | DB09269 | |
| 0.036 | 0.343 | 0.242 | Bone formation stimulant | 0.242 0.026 DB09269 | DB09269 | |
| 0.004 | 0.311 | 0.072 | Leukotriene B4 receptor 1 antagonist | 0.072 0.004 DB09269 | DB09269 | |
| 0.016 | 0.324 | 0.05 | Vanilloid 3 antagonist | 0.05 0.009 DB09269 | DB09269 | |
| 0.011 | 0.32 | 0.048 | Melatonin receptor 1A agonist | 0.048 0.009 DB09269 | DB09269 | |
| 0.007 | 0.316 | 0.088 | Nicotinic acid receptor agonist | 0.088 0.005 DB09269 | DB09269 | |
| 0.041 | 0.353 | 0.3 | Phospholipase A2 inhibitor | 0.3 0.014 DB09269 | DB09269 | |
| 0.002 | 0.314 | 0.013 | Adenosine A2a receptor agonist | 0.013 0.012 DB09269 | DB09269 | |
| 0.028 | 0.341 | 0.49 | Ferrochelatase inhibitor | 0.49 0.003 DB09269 | DB09269 | |
| 0.021 | 0.334 | 0.078 | Pregnane X receptor antagonist | 0.078 0.007 DB09269 | DB09269 | |
| 0.04 | 0.353 | 0.22 | Anticoagulant | 0.22 0.046 DB09269 | DB09269 | |
| 0.025 | 0.34 | 0.156 | DNA helicase inhibitor | 0.156 0.003 DB09269 | DB09269 | |
| 0.008 | 0.324 | 0.044 | Oxytocin agonist | 0.044 0.028 DB09269 | DB09269 | |
| 0.133 | 0.454 | 0.501 | Calcium channel L-type activator | 0.501 0.027 DB09269 | DB09269 | |
| 0.031 | 0.356 | 0.08 | Estrogen receptor alpha antagonist | 0.08 0.049 DB09269 | DB09269 | |
| 0.029 | 0.355 | 0.115 | Chelator | 0.115 0.059 DB09269 | DB09269 | |
| 0.015 | 0.343 | 0.129 | CDC25A inhibitor | 0.129 0.017 DB09269 | DB09269 | |
| 0.01 | 0.339 | 0.17 | AMPA 4 receptor antagonist | 0.17 0.004 DB09269 | DB09269 | |
| 0.022 | 0.352 | 0.07 | Calcium channel L-type blocker | 0.07 0.052 DB09269 | DB09269 | |
| 0.014 | 0.345 | 0.468 | Histidine decarboxylase inhibitor | 0.468 0.003 DB09269 | DB09269 | |
| 0.018 | 0.35 | 0.111 | Prostaglandin F2 alpha antagonist | 0.111 0.008 DB09269 | DB09269 | |
| 0.03 | 0.364 | 0.249 | Thrombolytic | 0.249 0.034 DB09269 | DB09269 | |
| 0.003 | 0.341 | 0.077 | Integrin alpha4beta7 antagonist | 0.077 0.004 DB09269 | DB09269 | |
| 0.015 | 0.352 | 0.177 | Carnitine palmitoyltransferase 1B inhibitor | 0.177 0.003 DB09269 | DB09269 | |
| 0.04 | 0.378 | 0.267 | Interleukin 8 antagonist | 0.267 0.005 DB09269 | DB09269 | |
| 0.002 | 0.341 | 0.119 | Prostaglandin E2 agonist | 0.119 0.004 DB09269 | DB09269 | |
| 0.007 | 0.346 | 0.134 | NMDA 2C receptor antagonist | 0.134 0.008 DB09269 | DB09269 | |
| 0.007 | 0.346 | 0.098 | NMDA 2A receptor antagonist | 0.098 0.014 DB09269 | DB09269 | |
| 0.034 | 0.374 | 0.31 | Cyclooxygenase inhibitor | 0.31 0.016 DB09269 | DB09269 | |
| 0.008 | 0.349 | 0.049 | RNA-directed RNA polymerase inhibitor | 0.049 0.013 DB09269 | DB09269 | |
| 0.024 | 0.366 | 0.109 | Gastric antisecretory | 0.109 0.054 DB09269 | DB09269 | |
| 0.002 | 0.343 | 0.087 | Kainate receptor 1 antagonist | 0.087 0.004 DB09269 | DB09269 | |
| 0.004 | 0.346 | 0.048 | Phosphoglycerate kinase inhibitor | 0.048 0.015 DB09269 | DB09269 | |
| 0.005 | 0.347 | 0.183 | NMDA receptor subunit 3A antagonist | 0.183 0.004 DB09269 | DB09269 | |
| 0.01 | 0.352 | 0.162 | Leukotriene antagonist | 0.162 0.009 DB09269 | DB09269 | |
| 0.003 | 0.346 | 0.123 | VLA-4 antagonist | 0.123 0.005 DB09269 | DB09269 | |
| 0.056 | 0.399 | 0.144 | Pregnane X receptor agonist | 0.125 0.115 DBMET02395 0.144 0.064 DB09269 | DB09269 | |
| 0.004 | 0.35 | 0.072 | Geranyltranstransferase inhibitor | 0.072 0.007 DB09269 | DB09269 | |
| 0.008 | 0.353 | 0.031 | ICAM 1 antagonist | 0.031 0.006 DB09269 | DB09269 | |
| 0.019 | 0.369 | 0.056 | CXC chemokine 1 receptor antagonist | 0.056 0.027 DB09269 | DB09269 | |
| 0.029 | 0.38 | 0.188 | GABA B receptor agonist | 0.188 0.004 DB09269 | DB09269 | |
| 0.024 | 0.378 | 0.306 | GABA C receptor antagonist | 0.306 0.004 DB09269 | DB09269 | |
| 0.012 | 0.37 | 0.111 | Thromboxane synthase inhibitor | 0.111 0.005 DB09269 | DB09269 | |
| 0.016 | 0.375 | 0.082 | Leukotriene C4 antagonist | 0.082 0.004 DB09269 | DB09269 | |
| 0.006 | 0.367 | 0.076 | Thyroid hormone agonist | 0.076 0.003 DB09269 | DB09269 | |
| 0.038 | 0.399 | 0.092 | Phosphodiesterase 6D inhibitor | 0.092 0.071 DB09269 | DB09269 | |
| 0.005 | 0.367 | 0.052 | Nicotinic acid receptor 2 antagonist | 0.052 0.004 DB09269 | DB09269 | |
| 0.004 | 0.366 | 0.12 | Peroxisome proliferator-activated receptor delta agonist | 0.12 0.005 DB09269 | DB09269 | |
| 0.003 | 0.366 | 0.082 | Integrin beta7 antagonist | 0.082 0.005 DB09269 | DB09269 | |
| 0.004 | 0.368 | 0.111 | Vitronectin receptor antagonist | 0.111 0.004 DB09269 | DB09269 | |
| 0.032 | 0.397 | 0.088 | MAP kinase kinase 7 inhibitor | 0.075 0.062 DBMET02395 0.088 0.028 DB09269 | DB09269 | |
| 0.012 | 0.378 | 0.079 | AICAR transformylase inhibitor | 0.079 0.008 DB09269 | DB09269 | |
| 0.025 | 0.393 | 0.161 | Glutathione S-transferase inhibitor | 0.161 0.01 DB09269 | DB09269 | |
| 0.015 | 0.384 | 0.238 | NMDA receptor agonist | 0.238 0.004 DB09269 | DB09269 | |
| 0.035 | 0.406 | 0.316 | DOPA decarboxylase inhibitor | 0.316 0.002 DB09269 | DB09269 | |
| 0.009 | 0.382 | 0.216 | NMDA receptor antagonist | 0.216 0.012 DB09269 | DB09269 | |
| 0.004 | 0.377 | 0.069 | Leukotriene D4 antagonist | 0.069 0.008 DB09269 | DB09269 | |
| 0.005 | 0.377 | 0.078 | Phosphorylase inhibitor | 0.078 0.017 DB09269 | DB09269 | |
| 0.017 | 0.389 | 0.098 | Heparanase inhibitor | 0.098 0.004 DB09269 | DB09269 | |
| 0.005 | 0.378 | 0.04 | Purinergic P2Y antagonist | 0.04 0.036 DB09269 | DB09269 | |
| 0.006 | 0.381 | 0.312 | Peroxisome proliferator-activated receptor delta antagonist | 0.312 0.003 DB09269 | DB09269 | |
| 0.03 | 0.405 | 0.198 | Cathepsin H inhibitor | 0.198 0.023 DB09269 | DB09269 | |
| 0.018 | 0.393 | 0.23 | Cathepsin G inhibitor | 0.23 0.014 DB09269 | DB09269 | |
| 0.022 | 0.4 | 0.108 | Leukotriene C antagonist | 0.108 0.004 DB09269 | DB09269 | |
| 0.01 | 0.391 | 0.203 | Monophenol monooxygenase inhibitor | 0.203 0.032 DB09269 | DB09269 | |
| 0.004 | 0.386 | 0.078 | Sphingosine 1-phosphate receptor 1 agonist | 0.078 0.006 DB09269 | DB09269 | |
| 0.004 | 0.389 | 0.099 | Prostaglandin EP4 antagonist | 0.099 0.004 DB09269 | DB09269 | |
| 0.019 | 0.405 | 0.145 | Falcipain 3 inhibitor | 0.145 0.039 DB09269 | DB09269 | |
| 0.008 | 0.395 | 0.074 | HIV-1 integrase (Strand Transfer) inhibitor | 0.074 0.034 DB09269 | DB09269 | |
| 0.032 | 0.421 | 0.208 | Toll-Like receptor 2 antagonist | 0.208 0.02 DB09269 | DB09269 | |
| 0.005 | 0.395 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.017 DBMET02395 0.029 0.018 DB09269 | DBMET02395 | |
| 0.01 | 0.401 | 0.045 | Plasmepsin II inhibitor | 0.045 0.022 DB09269 | DB09269 | |
| 0.004 | 0.395 | 0.032 | Endothelin receptor antagonist | 0.032 0.016 DB09269 | DB09269 | |
| 0.011 | 0.404 | 0.06 | Cholesterol esterase inhibitor | 0.06 0.018 DB09269 | DB09269 | |
| 0.01 | 0.404 | 0.066 | GABA B receptor antagonist | 0.066 0.01 DB09269 | DB09269 | |
| 0.037 | 0.434 | 0.525 | Peroxidase inhibitor | 0.525 0.008 DB09269 | DB09269 | |
| 0.007 | 0.406 | 0.022 | Tryptophan hydroxylase 1 inhibitor | 0.022 0.005 DB09269 | DB09269 | |
| 0.038 | 0.438 | 0.24 | Free radical scavenger | 0.24 0.073 DB09269 | DB09269 | |
| 0.002 | 0.402 | 0.029 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 DB09269 | DB09269 | |
| 0.01 | 0.41 | 0.075 | Tryptophan 5 hydroxylase inhibitor | 0.075 0.003 DB09269 | DB09269 | |
| 0.107 | 0.509 | 0.597 | 5 Hydroxytryptamine release inhibitor | 0.597 0.011 DB09269 | DB09269 | |
| 0.043 | 0.446 | 0.091 | CC chemokine 5 receptor agonist | 0.077 0.076 DBMET02395 0.091 0.034 DB09269 | DB09269 | |
| 0.007 | 0.412 | 0.146 | NMDA receptor glycine site agonist | 0.146 0.005 DB09269 | DB09269 | |
| 0.006 | 0.412 | 0.028 | Peptide deformylase inhibitor | 0.028 0.023 DB09269 | DB09269 | |
| 0.025 | 0.432 | 0.273 | GABA C receptor rho-1 antagonist | 0.273 0.004 DB09269 | DB09269 | |
| 0.028 | 0.438 | 0.242 | Electrolyte absorption antagonist | 0.242 0.005 DB09269 | DB09269 | |
| 0.006 | 0.418 | 0.117 | Lysophosphatidic acid 2 receptor antagonist | 0.117 0.004 DB09269 | DB09269 | |
| 0.04 | 0.453 | 0.095 | Hematopoietic | 0.095 0.041 DB09269 | DB09269 | |
| 0.022 | 0.436 | 0.169 | Interleukin 1 beta converting enzyme inhibitor | 0.169 0.011 DB09269 | DB09269 | |
| 0.018 | 0.432 | 0.145 | Peroxisome proliferator-activated receptor gamma antagonist | 0.145 0.006 DB09269 | DB09269 | |
| 0.013 | 0.429 | 0.072 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.072 0.004 DB09269 | DB09269 | |
| 0.043 | 0.459 | 0.14 | Glutamate release inhibitor | 0.14 0.013 DB09269 | DB09269 | |
| 0.01 | 0.428 | 0.512 | Porphobilinogen synthase inhibitor | 0.512 0.003 DB09269 | DB09269 | |
| 0.011 | 0.43 | 0.067 | Beta 2 adrenoreceptor antagonist | 0.067 0.018 DB09269 | DB09269 | |
| 0.017 | 0.437 | 0.06 | Topoisomerase II beta inhibitor | 0.06 0.022 DB09269 | DB09269 | |
| 0.02 | 0.441 | 0.05 | Vanilloid 2 antagonist | 0.05 0.041 DB09269 | DB09269 | |
| 0.006 | 0.427 | 0.049 | Metalloproteinase-3 inhibitor | 0.049 0.034 DB09269 | DB09269 | |
| 0.014 | 0.437 | 0.084 | Beta adrenoreceptor antagonist | 0.084 0.024 DB09269 | DB09269 | |
| 0.015 | 0.44 | 0.136 | Carbonic anhydrase XIII inhibitor | 0.136 0.025 DB09269 | DB09269 | |
| 0.02 | 0.446 | 0.21 | Cyclooxygenase 2 inhibitor | 0.21 0.028 DB09269 | DB09269 | |
| 0.01 | 0.436 | 0.071 | CDC25B inhibitor | 0.071 0.037 DB09269 | DB09269 | |
| 0.025 | 0.451 | 0.151 | Proteasome inhibitor | 0.151 0.046 DB09269 | DB09269 | |
| 0.006 | 0.435 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.022 DB09269 | DB09269 | |
| 0.088 | 0.517 | 0.169 | Heat shock protein 70 antagonist | 0.169 0.018 DB09269 | DB09269 | |
| 0.087 | 0.519 | 0.277 | Nitric-oxide synthase stimulant | 0.172 0.149 DBMET02395 0.277 0.018 DB09269 | DB09269 | |
| 0.022 | 0.455 | 0.164 | Carbonic anhydrase VI inhibitor | 0.164 0.018 DB09269 | DB09269 | |
| 0.017 | 0.451 | 0.125 | Histamine N-methyltransferase inhibitor | 0.125 0.026 DB09269 | DB09269 | |
| 0.003 | 0.438 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.014 DB09269 | DB09269 | |
| 0.012 | 0.449 | 0.092 | Sphingosine 1-phosphate receptor 3 antagonist | 0.092 0.01 DB09269 | DB09269 | |
| 0.04 | 0.479 | 0.196 | Hexokinase inhibitor | 0.196 0.038 DB09269 | DB09269 | |
| 0.025 | 0.464 | 0.082 | Thioredoxin inhibitor | 0.082 0.077 DB09269 | DB09269 | |
| 0.025 | 0.464 | 0.073 | Immunoglobulin Fc receptor antagonist | 0.073 0.009 DB09269 | DB09269 | |
| 0.007 | 0.447 | 0.06 | Carbonic anhydrase XIV inhibitor | 0.06 0.025 DB09269 | DB09269 | |
| 0.001 | 0.441 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DB09269 | DB09269 | |
| 0.008 | 0.45 | 0.079 | Matrix metalloproteinase inhibitor | 0.079 0.038 DB09269 | DB09269 | |
| 0.003 | 0.446 | 0.123 | Kainate receptor 2 antagonist | 0.123 0.004 DB09269 | DB09269 | |
| 0.027 | 0.472 | 0.2 | Carbonic anhydrase III inhibitor | 0.2 0.016 DB09269 | DB09269 | |
| 0.049 | 0.494 | 0.133 | MAP kinase 3 inhibitor | 0.133 0.099 DB09269 | DB09269 | |
| 0.031 | 0.476 | 0.2 | TRPA1 agonist | 0.2 0.01 DB09269 | DB09269 | |
| 0.04 | 0.489 | 0.099 | Interleukin 12 antagonist | 0.099 0.055 DB09269 | DB09269 | |
| 0.004 | 0.457 | 0.206 | NMDA receptor subunit 3B antagonist | 0.206 0.004 DB09269 | DB09269 | |
| 0.007 | 0.462 | 0.066 | Prolyl endopeptidase inhibitor | 0.066 0.019 DB09269 | DB09269 | |
| 0.021 | 0.475 | 0.094 | Exportin-1 inhibitor | 0.094 0.012 DB09269 | DB09269 | |
| 0.017 | 0.473 | 0.151 | Purinergic P2X1 antagonist | 0.151 0.007 DB09269 | DB09269 | |
| 0.009 | 0.466 | 0.228 | Sphingosine 1-phosphate receptor 4 agonist | 0.228 0.004 DB09269 | DB09269 | |
| 0.008 | 0.467 | 0.076 | Aminopeptidase N inhibitor | 0.076 0.018 DB09269 | DB09269 | |
| 0.027 | 0.486 | 0.362 | Insulin sensitizer | 0.362 0.008 DB09269 | DB09269 | |
| 0.03 | 0.49 | 0.126 | Nav1.2 sodium channel blocker | 0.126 0.077 DB09269 | DB09269 | |
| 0.012 | 0.473 | 0.096 | Aminopeptidase microsomal inhibitor | 0.096 0.019 DB09269 | DB09269 | |
| 0.004 | 0.466 | 0.018 | Kainate receptor 3 antagonist | 0.018 0.01 DB09269 | DB09269 | |
| 0.061 | 0.523 | 0.387 | Immunomodulator | 0.387 0.048 DBMET00945 0.27 0.1 DB09269 | DBMET00945 | |
| 0.01 | 0.474 | 0.108 | Metalloproteinase-2 inhibitor | 0.108 0.035 DB09269 | DB09269 | |
| 0.007 | 0.472 | 0.044 | Endothelin-converting enzyme inhibitor | 0.044 0.035 DB09269 | DB09269 | |
| 0.009 | 0.475 | 0.076 | Epoxide hydrolase inhibitor | 0.076 0.046 DB09269 | DB09269 | |
| 0.004 | 0.47 | 0.039 | Leukotriene A4 hydrolase inhibitor | 0.039 0.026 DB09269 | DB09269 | |
| 0.03 | 0.499 | 0.166 | Carbonic anhydrase XV inhibitor | 0.166 0.026 DB09269 | DB09269 | |
| 0.007 | 0.476 | 0.069 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.039 DB09269 | DB09269 | |
| 0.009 | 0.479 | 0.12 | Diacylglycerol O-acyltransferase inhibitor | 0.12 0.005 DB09269 | DB09269 | |
| 0.004 | 0.477 | 0.03 | Acid ceramidase inhibitor | 0.03 0.01 DB09269 | DB09269 | |
| 0.021 | 0.494 | 0.105 | Chymotrypsin inhibitor | 0.105 0.033 DB09269 | DB09269 | |
| 0.003 | 0.477 | 0.028 | Cholecystokinin B antagonist | 0.028 0.024 DB09269 | DB09269 | |
| 0.04 | 0.515 | 0.229 | DNA damaging | 0.229 0.093 DB09269 | DB09269 | |
| 0.003 | 0.477 | 0.073 | Kynurenine 3 monooxygenase inhibitor | 0.073 0.004 DB09269 | DB09269 | |
| 0.006 | 0.481 | 0.067 | Matrix metalloproteinase (membrane-type) inhibitor | 0.067 0.026 DB09269 | DB09269 | |
| 0.017 | 0.492 | 0.233 | Potassium channel (Ca-activated) activator | 0.233 0.009 DB09269 | DB09269 | |
| 0.004 | 0.48 | 0.024 | Kainate receptor 4 antagonist | 0.024 0.018 DB09269 | DB09269 | |
| 0.027 | 0.503 | 0.252 | Aldehyde dehydrogenase inhibitor | 0.252 0.018 DB09269 | DB09269 | |
| 0.003 | 0.48 | 0.165 | Kainate receptor antagonist | 0.165 0.004 DB09269 | DB09269 | |
| 0.013 | 0.493 | 0.081 | Botulinum neurotoxin type A inhibitor | 0.081 0.016 DB09269 | DB09269 | |
| 0.017 | 0.5 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.077 0.026 DB09269 | DB09269 | |
| 0.004 | 0.49 | 0.108 | Carbonic anhydrase VB inhibitor | 0.108 0.014 DB09269 | DB09269 | |
| 0.004 | 0.491 | 0.096 | Sphingosine 1-phosphate receptor agonist | 0.096 0.006 DB09269 | DB09269 | |
| 0.006 | 0.494 | 0.057 | Integrin alpha2beta1 antagonist | 0.057 0.004 DB09269 | DB09269 | |
| 0.015 | 0.504 | 0.08 | Dihydroorotate oxidase inhibitor | 0.08 0.011 DB09269 | DB09269 | |
| 0.016 | 0.507 | 0.048 | Integrin alpha1beta1 antagonist | 0.048 0.009 DB09269 | DB09269 | |
| 0.004 | 0.495 | 0.092 | Liver X receptor beta antagonist | 0.092 0.004 DB09269 | DB09269 | |
| 0.003 | 0.498 | 0.055 | Oleamide hydrolase inhibitor | 0.055 0.023 DB09269 | DB09269 | |
| 0.004 | 0.499 | 0.058 | Leukocyte elastase inhibitor | 0.058 0.019 DB09269 | DB09269 | |
| 0.022 | 0.519 | 0.213 | Mannose-6-phosphate isomerase inhibitor | 0.213 0.024 DB09269 | DB09269 | |
| 0.004 | 0.501 | 0.049 | Glutamate (mGluR group I) agonist | 0.049 0.032 DB09269 | DB09269 | |
| 0.005 | 0.502 | 0.298 | Aldose reductase inhibitor | 0.298 0.004 DB09269 | DB09269 | |
| 0.001 | 0.499 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.017 0.005 DB09269 | DB09269 | |
| 0.017 | 0.515 | 0.152 | Caspase 3 inhibitor | 0.152 0.027 DB09269 | DB09269 | |
| 0.003 | 0.503 | 0.043 | Glutamate (mGluR group II) antagonist | 0.043 0.022 DB09269 | DB09269 | |
| 0.034 | 0.538 | 0.24 | GABA C receptor rho-2 antagonist | 0.24 0.014 DB09269 | DB09269 | |
| 0.006 | 0.511 | 0.052 | Xanthine dehydrogenase inhibitor | 0.052 0.044 DB09269 | DB09269 | |
| 0.056 | 0.561 | 0.235 | Neurotensin receptor agonist | 0.235 0.024 DB09269 | DB09269 | |
| 0.011 | 0.518 | 0.077 | Dopamine beta hydroxylase inhibitor | 0.077 0.005 DB09269 | DB09269 | |
| 0.003 | 0.512 | 0.021 | Kainate receptor 5 antagonist | 0.021 0.014 DB09269 | DB09269 | |
| 0.019 | 0.529 | 0.185 | Potassium channel large-conductance Ca-activated activator | 0.185 0.007 DB09269 | DB09269 | |
| 0.044 | 0.557 | 0.236 | Sphingosine 1-phosphate receptor 5 antagonist | 0.236 0.004 DB09269 | DB09269 | |
| 0.017 | 0.532 | 0.102 | CD45 antagonist | 0.102 0.009 DB09269 | DB09269 | |
| 0.007 | 0.523 | 0.2 | Protein-tyrosine phosphatase 1B inhibitor | 0.2 0.029 DB09269 | DB09269 | |
| 0.013 | 0.533 | 0.124 | Macrophage migration inhibitory factor inhibitor | 0.124 0.024 DB09269 | DB09269 | |
| 0.062 | 0.583 | 0.51 | GABA C receptor rho-3 antagonist | 0.51 0.023 DB09269 | DB09269 | |
| 0.03 | 0.551 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.116 0.016 DB09269 | DB09269 | |
| 0.01 | 0.533 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.022 DB09269 | DB09269 | |
| 0.003 | 0.532 | 0.034 | Glucagon receptor antagonist | 0.034 0.017 DB09269 | DB09269 | |
| 0.026 | 0.557 | 0.131 | Interleukin 5 antagonist | 0.131 0.017 DB09269 | DB09269 | |
| 0.011 | 0.542 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 DB09269 | DB09269 | |
| 0.007 | 0.54 | 0.089 | Metalloproteinase-9 inhibitor | 0.089 0.038 DB09269 | DB09269 | |
| 0.01 | 0.544 | 0.236 | Alcohol dehydrogenase inhibitor | 0.236 0.009 DB09269 | DB09269 | |
| 0.003 | 0.538 | 0.084 | Prostaglandin EP3 antagonist | 0.084 0.007 DB09269 | DB09269 | |
| 0.001 | 0.538 | 0.022 | Angiotensin AT1B receptor antagonist | 0.022 0.005 DB09269 | DB09269 | |
| 0.005 | 0.544 | 0.05 | Nerve growth factor antagonist | 0.05 0.018 DB09269 | DB09269 | |
| 0.004 | 0.543 | 0.066 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.066 0.005 DB09269 | DB09269 | |
| 0.008 | 0.549 | 0.05 | VCAM-1 antagonist | 0.05 0.009 DB09269 | DB09269 | |
| 0.008 | 0.549 | 0.05 | VCAM antagonist | 0.05 0.009 DB09269 | DB09269 | |
| 0.019 | 0.56 | 0.125 | Xanthine oxidase inhibitor | 0.125 0.045 DB09269 | DB09269 | |
| 0.002 | 0.543 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 DB09269 | DB09269 | |
| 0.021 | 0.563 | 0.204 | Sphingosine 1-phosphate receptor 2 antagonist | 0.204 0.007 DB09269 | DB09269 | |
| 0.007 | 0.55 | 0.074 | Integrin alpha2 antagonist | 0.074 0.005 DB09269 | DB09269 | |
| 0.002 | 0.552 | 0.023 | Complement factor D inhibitor | 0.023 0.005 DB09269 | DB09269 | |
| 0.004 | 0.555 | 0.082 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.082 0.024 DB09269 | DB09269 | |
| 0.007 | 0.559 | 0.077 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 DB09269 | DB09269 | |
| 0.022 | 0.576 | 0.361 | Platelet aggregation inhibitor | 0.361 0.024 DB09269 | DB09269 | |
| 0.02 | 0.574 | 0.155 | Antibacterial (Helicobacter pylori) | 0.155 0.042 DB09269 | DB09269 | |
| 0.009 | 0.565 | 0.11 | Carbonic anhydrase stimulant | 0.11 0.016 DB09269 | DB09269 | |
| 0 | 0.556 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DB09269 | DB09269 | |
| 0.005 | 0.563 | 0.11 | Liver X receptor alpha antagonist | 0.11 0.004 DB09269 | DB09269 | |
| 0.003 | 0.561 | 0.099 | NMDA 2 receptor antagonist | 0.099 0.032 DB09269 | DB09269 | |
| 0.005 | 0.562 | 0.126 | Liver X receptor alpha agonist | 0.126 0.004 DB09269 | DB09269 | |
| 0.049 | 0.609 | 0.387 | Insulysin inhibitor | 0.387 0.024 DB09269 | DB09269 | |
| 0.008 | 0.569 | 0.157 | Carbonic anhydrase VA inhibitor | 0.157 0.009 DB09269 | DB09269 | |
| 0.004 | 0.566 | 0.053 | Angiotensin II receptor antagonist | 0.053 0.005 DB09269 | DB09269 | |
| 0.003 | 0.565 | 0.036 | TRPM8 blocker | 0.036 0.03 DB09269 | DB09269 | |
| 0.009 | 0.572 | 0.059 | Cytokine production stimulant | 0.059 0.014 DB09269 | DB09269 | |
| 0.005 | 0.568 | 0.066 | Phosphodiesterase 4B inhibitor | 0.066 0.048 DB09269 | DB09269 | |
| 0.022 | 0.586 | 0.216 | Sphingosine 1-phosphate receptor 4 antagonist | 0.216 0.007 DB09269 | DB09269 | |
| 0.008 | 0.576 | 0.13 | Leukotriene synthesis inhibitor | 0.13 0.013 DB09269 | DB09269 | |
| 0.038 | 0.606 | 0.122 | NOS3 expression enhancer | 0.122 0.112 DB09269 | DB09269 | |
| 0.003 | 0.572 | 0.055 | Dihydropteroate synthase inhibitor | 0.055 0.014 DB09269 | DB09269 | |
| 0.002 | 0.572 | 0.049 | Carbonic anhydrase IV inhibitor | 0.049 0.025 DB09269 | DB09269 | |
| 0.008 | 0.579 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DB09269 | DB09269 | |
| 0.004 | 0.575 | 0.095 | Neutrophil collagenase inhibitor | 0.095 0.024 DB09269 | DB09269 | |
| 0.006 | 0.581 | 0.171 | Carbonic anhydrase V inhibitor | 0.171 0.01 DB09269 | DB09269 | |
| 0.003 | 0.578 | 0.105 | AMPA 3 receptor antagonist | 0.105 0.004 DB09269 | DB09269 | |
| 0.007 | 0.582 | 0.102 | Plasminogen activator inhibitor antagonist | 0.102 0.01 DB09269 | DB09269 | |
| 0.01 | 0.587 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.036 DB09269 | DB09269 | |
| 0.004 | 0.583 | 0.047 | Cholecystokinin antagonist | 0.047 0.026 DB09269 | DB09269 | |
| 0.003 | 0.582 | 0.061 | Angiotensin AT1 receptor antagonist | 0.061 0.005 DB09269 | DB09269 | |
| 0.002 | 0.582 | 0.062 | Fructose-1,6-bisphosphatase inhibitor | 0.062 0.016 DB09269 | DB09269 | |
| 0.008 | 0.588 | 0.054 | Plasminogen activator inhibitor | 0.054 0.044 DB09269 | DB09269 | |
| 0.004 | 0.586 | 0.334 | Prostaglandin EP2 antagonist | 0.334 0.004 DB09269 | DB09269 | |
| 0.006 | 0.59 | 0.05 | Dihydroorotase inhibitor | 0.05 0.025 DB09269 | DB09269 | |
| 0.024 | 0.611 | 0.195 | NADPH oxidase inhibitor | 0.195 0.036 DB09269 | DB09269 | |
| 0.013 | 0.601 | 0.056 | Heme oxygenase inhibitor | 0.056 0.008 DB09269 | DB09269 | |
| 0.014 | 0.601 | 0.189 | Uric acid excretion stimulant | 0.189 0.014 DB09269 | DB09269 | |
| 0.004 | 0.593 | 0.229 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.229 0.004 DB09269 | DB09269 | |
| 0.004 | 0.594 | 0.042 | Histamine H1 receptor agonist | 0.042 0.034 DB09269 | DB09269 | |
| 0.001 | 0.593 | 0.011 | Beta 3 adrenoreceptor agonist | 0.011 0.009 DB09269 | DB09269 | |
| 0.002 | 0.599 | 0.044 | Methionyl aminopeptidase 1 inhibitor | 0.044 0.009 DB09269 | DB09269 | |
| 0.001 | 0.599 | 0.056 | NMDA receptor glycine site antagonist | 0.056 0.005 DB09269 | DB09269 | |
| 0.005 | 0.602 | 0.075 | Glucagon-like peptide 1 agonist | 0.075 0.038 DB09269 | DB09269 | |
| 0.082 | 0.681 | 0.206 | 5 Hydroxytryptamine 3E antagonist | 0.206 0.052 DB09269 | DB09269 | |
| 0.089 | 0.702 | 0.434 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.434 0.073 DB09269 | DB09269 | |
| 0.003 | 0.619 | 0.801 | Prostaglandin D2 antagonist | 0.801 0.002 DB09269 | DB09269 | |
| 0.003 | 0.622 | 0.04 | Calcium-sensing receptor agonist | 0.04 0.008 DB09269 | DB09269 | |
| 0.016 | 0.636 | 0.309 | Lipoxygenase inhibitor | 0.309 0.067 DB09269 | DB09269 | |
| 0.005 | 0.625 | 0.116 | Liver X receptor antagonist | 0.116 0.005 DB09269 | DB09269 | |
| 0.001 | 0.622 | 0.108 | AMPA 1 receptor antagonist | 0.108 0.005 DB09269 | DB09269 | |
| 0.003 | 0.624 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 DB09269 | DB09269 | |
| 0.002 | 0.624 | 0.04 | Diamine oxidase inhibitor | 0.04 0.023 DB09269 | DB09269 | |
| 0.005 | 0.628 | 0.041 | Histamine H2 receptor agonist | 0.041 0.033 DB09269 | DB09269 | |
| 0.002 | 0.626 | 0.117 | Urate transporter 1 inhibitor | 0.117 0.005 DB09269 | DB09269 | |
| 0.009 | 0.636 | 0.096 | Caspase 7 inhibitor | 0.096 0.034 DB09269 | DB09269 | |
| 0.005 | 0.634 | 0.101 | Liver X receptor agonist | 0.101 0.007 DB09269 | DB09269 | |
| 0.001 | 0.633 | 0.011 | Thrombopoietin agonist | 0.011 0.01 DB09269 | DB09269 | |
| 0.003 | 0.636 | 0.075 | Thymidylate synthase inhibitor | 0.075 0.009 DB09269 | DB09269 | |
| 0.007 | 0.642 | 0.089 | CYP2A6 inhibitor | 0.089 0.042 DB09269 | DB09269 | |
| 0.004 | 0.64 | 0.097 | Glutamate receptor agonist | 0.097 0.039 DB09269 | DB09269 | |
| 0.018 | 0.654 | 0.177 | Antiamyloidogenic | 0.177 0.117 DB09269 | DB09269 | |
| 0.012 | 0.65 | 0.126 | Nav1.6 sodium channel blocker | 0.126 0.086 DB09269 | DB09269 | |
| 0.002 | 0.643 | 0.036 | Sirtuin 2 inhibitor | 0.036 0.02 DB09269 | DB09269 | |
| 0.008 | 0.656 | 0.264 | Protein-tyrosine phosphatase inhibitor | 0.264 0.027 DB09269 | DB09269 | |
| 0.01 | 0.659 | 0.081 | Myeloperoxidase inhibitor | 0.081 0.065 DB09269 | DB09269 | |
| 0.038 | 0.689 | 0.098 | Factor V inhibitor | 0.098 0.074 DB09269 | DB09269 | |
| 0.003 | 0.657 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.026 DB09269 | DB09269 | |
| 0.028 | 0.682 | 0.166 | CF transmembrane conductance regulator agonist | 0.166 0.052 DB09269 | DB09269 | |
| 0.018 | 0.673 | 0.142 | Interleukin 1 antagonist | 0.142 0.063 DB09269 | DB09269 | |
| 0.011 | 0.666 | 0.058 | Trypsin inhibitor | 0.058 0.054 DB09269 | DB09269 | |
| 0.009 | 0.665 | 0.096 | Beta amyloid protein antagonist | 0.096 0.095 DB09269 | DB09269 | |
| 0.003 | 0.66 | 0.1 | Liver X receptor beta agonist | 0.1 0.005 DB09269 | DB09269 | |
| 0.008 | 0.666 | 0.111 | Urease inhibitor | 0.111 0.054 DB09269 | DB09269 | |
| 0.007 | 0.665 | 0.083 | Sphingosine 1-phosphate receptor 1 antagonist | 0.083 0.013 DB09269 | DB09269 | |
| 0.001 | 0.661 | 0.033 | Egl nine homolog 1 inhibitor | 0.033 0.004 DB09269 | DB09269 | |
| 0.008 | 0.675 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DB09269 | DB09269 | |
| 0.01 | 0.677 | 0.097 | 5 Hydroxytryptamine 3A agonist | 0.097 0.079 DB09269 | DB09269 | |
| 0.001 | 0.67 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DB09269 | DB09269 | |
| 0.015 | 0.685 | 0.166 | Thiol protease inhibitor | 0.166 0.057 DB09269 | DB09269 | |
| 0.008 | 0.683 | 0.122 | GABA receptor agonist | 0.122 0.055 DB09269 | DB09269 | |
| 0.025 | 0.702 | 0.241 | Interleukin 4 antagonist | 0.241 0.014 DB09269 | DB09269 | |
| 0.008 | 0.69 | 0.068 | Adenosine A3 receptor antagonist | 0.068 0.061 DB09269 | DB09269 | |
| 0.022 | 0.704 | 0.416 | Antiobesity | 0.416 0.06 DB09269 | DB09269 | |
| 0.006 | 0.69 | 0.097 | Maillard reaction inhibitor | 0.097 0.018 DB09269 | DB09269 | |
| 0.02 | 0.705 | 0.291 | 15-Lipoxygenase inhibitor | 0.291 0.138 DB09269 | DB09269 | |
| 0.004 | 0.691 | 0.075 | Collagenase 3 inhibitor | 0.075 0.028 DB09269 | DB09269 | |
| 0.004 | 0.692 | 0.112 | AMPA 2 receptor antagonist | 0.112 0.005 DB09269 | DB09269 | |
| 0.006 | 0.695 | 0.069 | Glutamate (mGluR group III) agonist | 0.069 0.015 DB09269 | DB09269 | |
| 0.003 | 0.692 | 0.049 | Dihydrofolate reductase inhibitor | 0.049 0.019 DB09269 | DB09269 | |
| 0.006 | 0.7 | 0.101 | Sphingosine 1-phosphate receptor antagonist | 0.101 0.021 DB09269 | DB09269 | |
| 0.022 | 0.716 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | 0.173 0.071 DB09269 | DB09269 | |
| 0.008 | 0.705 | 0.136 | Alkaline phosphatase inhibitor | 0.136 0.07 DB09269 | DB09269 | |
| 0.01 | 0.709 | 0.164 | AMP-activated protein kinase stimulant | 0.164 0.02 DB09269 | DB09269 | |
| 0.023 | 0.728 | 0.124 | Transcription factor STAT6 inhibitor | 0.124 0.053 DB09269 | DB09269 | |
| 0.013 | 0.721 | 0.205 | 5 Hydroxytryptamine 1E antagonist | 0.205 0.125 DB09269 | DB09269 | |
| 0.002 | 0.716 | 0.032 | Prostaglandin EP1 antagonist | 0.032 0.009 DB09269 | DB09269 | |
| 0.009 | 0.728 | 0.259 | 12-Lipoxygenase inhibitor | 0.259 0.104 DB09269 | DB09269 | |
| 0.003 | 0.724 | 0.091 | Prostaglandin-E synthase inhibitor | 0.091 0.032 DB09269 | DB09269 | |
| 0.021 | 0.745 | 0.214 | Neuropeptide Y2 antagonist | 0.214 0.096 DB09269 | DB09269 | |
| 0.004 | 0.736 | 0.04 | Glutamate (mGluR4) agonist | 0.04 0.016 DB09269 | DB09269 | |
| 0.004 | 0.741 | 0.834 | Prostaglandin antagonist | 0.834 0.003 DB09269 | DB09269 | |
| 0.004 | 0.743 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.025 DB09269 | DB09269 | |
| 0.002 | 0.757 | 0.107 | AMPA receptor antagonist | 0.107 0.01 DB09269 | DB09269 | |
| 0.017 | 0.776 | 0.144 | Interleukin 1b antagonist | 0.144 0.045 DB09269 | DB09269 | |
| 0.005 | 0.767 | 0.024 | Complement factor 1s inhibitor | 0.024 0.022 DB09269 | DB09269 | |
| 0.003 | 0.767 | 0.041 | Stearoyl-CoA desaturase inhibitor | 0.041 0.036 DB09269 | DB09269 | |
| 0.004 | 0.771 | 0.098 | Inducible nitric-oxide synthase inhibitor | 0.098 0.039 DB09269 | DB09269 | |
| 0.003 | 0.77 | 0.112 | Protein kinase (CK2) alpha inhibitor | 0.112 0.067 DB09269 | DB09269 | |
| 0.014 | 0.788 | 0.246 | Hypoxia-inducible factor 1 alpha inhibitor | 0.246 0.105 DB09269 | DB09269 | |
| 0.005 | 0.783 | 0.183 | 5-Lipoxygenase inhibitor | 0.183 0.028 DB09269 | DB09269 | |
| 0.011 | 0.79 | 0.374 | Thyroid hormone antagonist | 0.374 0.065 DB09269 | DB09269 | |
| 0.005 | 0.791 | 0.16 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.16 0.131 DB09269 | DB09269 | |
| 0.011 | 0.801 | 0.326 | Thyroid hormone beta antagonist | 0.326 0.077 DB09269 | DB09269 | |
| 0.003 | 0.794 | 0.095 | Amidase inhibitor | 0.095 0.027 DB09269 | DB09269 | |
| 0.033 | 0.826 | 0.271 | Catenin beta inhibitor | 0.271 0.008 DB09269 | DB09269 | |
| 0.009 | 0.802 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 DB09269 | DB09269 | |
| 0.002 | 0.797 | 0.085 | Protein kinase (CK2) inhibitor | 0.085 0.077 DB09269 | DB09269 | |
| 0.004 | 0.802 | 0.095 | Prostaglandin E2 antagonist | 0.095 0.016 DB09269 | DB09269 | |
| 0.003 | 0.803 | 0.046 | Protocollagen prolyl hydroxylase inhibitor | 0.046 0.006 DB09269 | DB09269 | |
| 0.008 | 0.808 | 0.065 | Autotaxin inhibitor | 0.065 0.025 DB09269 | DB09269 | |
| 0.004 | 0.808 | 0.101 | Nitric-oxide synthase inhibitor | 0.101 0.058 DB09269 | DB09269 | |
| 0.004 | 0.814 | 0.246 | Calpain inhibitor | 0.246 0.069 DB09269 | DB09269 | |
| 0.005 | 0.817 | 0.189 | M17 leucyl aminopeptidase inhibitor | 0.189 0.037 DB09269 | DB09269 | |
| 0.007 | 0.819 | 0.404 | Interleukin antagonist | 0.404 0.03 DB09269 | DB09269 | |
| 0.004 | 0.832 | 0.12 | Phosphodiesterase 4D inhibitor | 0.12 0.028 DB09269 | DB09269 | |
| 0.004 | 0.832 | 0.26 | Calpain 2 inhibitor | 0.26 0.142 DB09269 | DB09269 | |
| 0.003 | 0.833 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 DB09269 | DB09269 | |
| 0.006 | 0.84 | 0.257 | Dual specificity phosphatase 3 inhibitor | 0.257 0.038 DB09269 | DB09269 | |
| 0.008 | 0.844 | 0.227 | Dual specificity phosphatase inhibitor | 0.227 0.044 DB09269 | DB09269 | |
| 0.005 | 0.841 | 0.136 | Glutamate receptor antagonist | 0.136 0.061 DB09269 | DB09269 | |
| 0.003 | 0.847 | 0.022 | Bombesin agonist | 0.022 0.015 DB09269 | DB09269 | |
| 0.005 | 0.863 | 0.199 | Transcription factor STAT3 inhibitor | 0.199 0.134 DB09269 | DB09269 | |
| 0.005 | 0.912 | 0.191 | Transcription factor STAT inhibitor | 0.191 0.151 DB09269 | DB09269 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |